MedTrace Logo

Compound Ciwujia Granules Treat Chronic Fatigue Syndrome

NCT06245642 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 235

Last updated 2025-09-23

No results posted yet for this study

Summary

To observe the improvement of Chalder scale score in patients with chronic fatigue syndrome treated by Compound Ciwujia Granules. Improvement =\[(baseline score - post-treatment score)/baseline score\]\*100%

Conditions

  • Chronic Fatigue Syndrome

Interventions

DRUG

Compound Ciwujia Granules, Guipi Granules

Experimental group: Basic treatment + Compound Ciwujia Granules + Guipi Granules simulator orally for 6 weeks; Positive drug control group: basic treatment + Guipi Granules + Compound Ciwujia Granules simulant orally for 6 weeks.

Sponsors & Collaborators

  • Heilongjiang Quanle Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Xiaotian Zhang, Master · Shanghai Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

  • Weian Yuan, Doctor · Shanghai Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-19
Primary Completion
2025-01-16
Completion
2025-01-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06245642 on ClinicalTrials.gov